|
|
20 May 2014 |
Advanced Medical Solutions Group plc
(“AMS”)
Annual General Meeting
Winsford, UK: Advanced Medical Solutions Group plc (AIM: AMS.L), the global medical technology company, will hold its Annual General Meeting (“AGM”) at 11.00 today at the offices of Tavistock Communications, 131 Finsbury Pavement, London, EC2A 1NT.
Chris Meredith, AMS’s Chief Executive Officer, will give a presentation at the AGM, the slides from which will be made available on the Company’s website www.admedsol.com. No new material information will be provided.
In line with last year’s practice, AMS will be providing an update on trading in late June.
– ends –
For further information, please contact:
|
Advanced Medical Solutions Group plc |
Tel: +44 (0) 1606 545508 |
|
Chris Meredith, Chief Executive Officer Mary Tavener, Group Finance Director |
|
|
|
|
|
Tavistock Communications |
Tel: +44 (0) 20 7920 3150 |
|
John West / Chris Munden / Andrew Dunn |
|
|
|
|
|
Investec Bank plc |
Tel: +44 (0) 20 7597 5970 |
|
Daniel Adams |
|
About Advanced Medical Solutions Group plc – see www.admedsol.com
Founded in 1991, AMS is a leader in the development and manufacture of innovative and technologically advanced products for the US$15 billion global wound care market. Through a mix of organic development and a number of acquisitions, AMS now has a wide range of products based on technologies that include alginates, silver alginates, foams, collagens, cyanoacrylate adhesives and sutures.
AMS manufactures wound care products for an extensive list of Original Equipment Manufacturer (“OEM”) customers around the world, but the majority of the Group’s revenues now come from its own brands – ActivHeal® wound care products in the UK to the NHS, LiquiBand® cyanoacrylate products primarily in the UK, Europe and the USA, and RESORBA® sutures and collagen wound care products primarily in Europe. AMS develops innovative products from its R&D pipeline which it commercialises globally, either directly or through partnerships with its OEM customers.
AMS’s products are sold globally via a network of regional or multinational partners and distributors, as well as via AMS’s own direct sales forces in the UK, Germany, the Czech Republic and Russia.
With 450 employees operating under four distinct business units (Branded Direct, Branded Distributed, OEM and Bulk Materials) that match its multiple products and routes-to-market, AMS’s products are manufactured from two sites in the UK, one in the Netherlands, two in Germany and one in the Czech Republic.
This information is provided by RNS
END
AGMSFAFIUFLSESI